Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will ...

The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...

Dividend stocks can make for great long-term investments. They can generate a steady stream of income for your portfolio, not ...

AbbVie Inc. (NYSE:ABBV) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On February 24, RBC Capital began coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a ...

For its third quarter, AbbVie reaped just under $15.78 billion in revenue, which was 9% higher on a year-over-year basis. This was led by the company's enviable collection of blockbuster drugs; ...

AbbVie’s model based fair value has been adjusted only slightly, moving from US$248.29 to US$248.86, which keeps the overall ...

AbbVie ABBV stock has declined 3.2% in a month. Shares of this large drugmaker dipped recently after it denied takeover talks with Redwood City, CA-based cancer biotech, Revolution Medicines RVMD.

Some valuation metrics suggest that AbbVie is a cheap stock. The company's growth prospects through 2030 look attractive. AbbVie is also an excellent dividend stock. 10 stocks we like better than ...

AbbVie Inc. (NYSE:ABBV) is one of the debt free halal stocks to buy. On March 3, at the TD Cowen 46th Annual Health Care Conference, AbbVie Inc. (NYSE:ABBV) affirmed its robust research and ...

AbbVie Inc. (NYSE: ABBV ) is one of the best undervalued stocks to invest in right now.

Shares of AbbVie Inc. ABBV shed 1.16% to $227.45 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.83% to 6,795.99 and the ...

I last covered AbbVie Inc. (ABBV)(ABBV:CA) on Nov 8 with an article titled “Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer.” The article served as a review of ABBV’s FQ3 earnings report ...